Digital Medication Management in Polypharmacy.

Robin BrünnJale BastenDorothea LemkeAlexandra PiotrowskiSara SölingBastian SurmannWolfgang GreinerDaniel GrandtPetra Kellermann-MühlhoffSebastian HarderPaul GlasziouRafael PereraJuliane Köberlein-NeuPeter IhleMarjan van den AkkerNina TimmesfeldChristiane Muthnull null

Published in: Deutsches Arzteblatt international (2024)

The planned analyses did not reveal any significant effect of the intervention. Pandemicadjusted analyses yielded evidence that the mortality of adult patients with polypharmacy might potentially be lowered by the CDSS. Controlled trials with appropriate follow-up are needed to prove that a CDSS has significant effects on mortality in patients with polypharmacy.

Keyphrases

adverse drug
cardiovascular events
randomized controlled trial
risk factors
healthcare
genome wide
emergency department
type diabetes
single cell
cardiovascular disease
drug induced